About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Current Pharmaceutical Biotechnology
›
Top Articles
Current Pharmaceutical Biotechnology
2.2
(top 20%)
impact factor
2.6K
(top 10%)
papers
56.6K
(top 5%)
citations
98
(top 5%)
h
-index
2.3
(top 20%)
impact factor
3.1K
all documents
59.6K
doc citations
145
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Phage Therapy in Clinical Practice: Treatment of Human Infections
Current Pharmaceutical Biotechnology
2010
550
2
Lantibiotics: Mode of Action, Biosynthesis and Bioengineering
Current Pharmaceutical Biotechnology
2009
446
3
Nutritional and Therapeutic Potential of Spirulina
Current Pharmaceutical Biotechnology
2005
376
4
Ganoderma lucidum: A Potent Pharmacological Macrofungus
Current Pharmaceutical Biotechnology
2009
343
5
Phage Choice, Isolation, and Preparation for Phage Therapy
Current Pharmaceutical Biotechnology
2010
334
6
CAR T-cell Therapy: A New Era in Cancer Immunotherapy
Current Pharmaceutical Biotechnology
2018
321
7
Essential Fatty Acids - A Review
Current Pharmaceutical Biotechnology
2006
320
8
Sports Medicine Applications of Platelet Rich Plasma
Current Pharmaceutical Biotechnology
2012
297
9
Bacteriophage for Biocontrol of Foodborne Pathogens: Calculations and Considerations
Current Pharmaceutical Biotechnology
2010
286
10
Cell Proliferation and Cytotoxicity Assays
Current Pharmaceutical Biotechnology
2016
284
11
Do the Fibrin Architecture and Leukocyte Content Influence the Growth Factor Release of Platelet Concentrates? An Evidence-based Answer Comparing a Pure Platelet-Rich Plasma (P-PRP) Gel and a Leukocyte- and Platelet-Rich Fibrin (L-PRF)
Current Pharmaceutical Biotechnology
2012
271
12
Gamma Linolenic Acid: An Antiinflammatory Omega-6 Fatty Acid
Current Pharmaceutical Biotechnology
2006
260
13
A Review on the Toxicity and Non-Target Effects of Macrocyclic Lactones in Terrestrial and Aquatic Environments
Current Pharmaceutical Biotechnology
2012
260
14
The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems
Current Pharmaceutical Biotechnology
2005
258
15
Mechanisms of Protein Aggregation
Current Pharmaceutical Biotechnology
2009
246
16
Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)
Current Pharmaceutical Biotechnology
2014
242
17
Joint Diseases and Matrix Metalloproteinases: A Role for MMP-13
Current Pharmaceutical Biotechnology
2008
241
18
The Use of Phages for the Removal of Infectious Biofilms
Current Pharmaceutical Biotechnology
2008
239
19
Immune Responses to Therapeutic Proteins in Humans - Clinical Significance, Assessment and Prediction
Current Pharmaceutical Biotechnology
2002
239
20
Monoclonal Antibodies as Innovative Therapeutics
Current Pharmaceutical Biotechnology
2008
235
21
Marine Sponges: Potential Sources of New Antimicrobial Drugs
Current Pharmaceutical Biotechnology
2009
229
22
Application of Chitin and Chitosan Derivatives in the Pharmaceutical Field
Current Pharmaceutical Biotechnology
2003
228
23
Heterogeneity of Monoclonal Antibodies Revealed by Charge-Sensitive Methods
Current Pharmaceutical Biotechnology
2008
228
24
Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins
Current Pharmaceutical Biotechnology
2008
228
25
Nanotechnology on Duty in Medical Applications
Current Pharmaceutical Biotechnology
2005
219
26
Curcumin and Liver Cancer: A Review
Current Pharmaceutical Biotechnology
2012
218
27
Phage Therapy Pharmacology
Current Pharmaceutical Biotechnology
2010
214
28
Modulating Poly (ADP-Ribose) Polymerase Activity: Potential for the Prevention and Therapy of Pathogenic Situations Involving DNA Damage and Oxidative Stress
Current Pharmaceutical Biotechnology
2002
212
29
Effect of Additives on Protein Aggregation
Current Pharmaceutical Biotechnology
2009
211
30
Current Knowledge and Perspectives for the Use of Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) in Oral and Maxillofacial Surgery Part 2: Bone Graft, Implant and Reconstructive Surgery
Current Pharmaceutical Biotechnology
2012
210
31
Structure-Function Relationships of the Non-Lanthionine-Containing Peptide (class II) Bacteriocins Produced by Gram-Positive Bacteria
Current Pharmaceutical Biotechnology
2009
208
32
The Potential of Microalgae for the Production of Bioactive Molecules of Pharmaceutical Interest
Current Pharmaceutical Biotechnology
2012
201
33
Current Knowledge and Perspectives for the Use of Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) in Oral and Maxillofacial Surgery Part 1: Periodontal and Dentoalveolar Surgery
Current Pharmaceutical Biotechnology
2012
201
34
In Search of a Consensus Terminology in the Field of Platelet Concentrates for Surgical Use: Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), Fibrin Gel Polymerization and Leukocytes
Current Pharmaceutical Biotechnology
2012
197
35
Lipid Metabolism During Pregnancy and its Implications for Fetal Growth
Current Pharmaceutical Biotechnology
2014
192
36
Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Biotechnology
2011
185
37
A Critical Review of Methods for Size Characterization of Non-Particulate Protein Aggregates
Current Pharmaceutical Biotechnology
2009
180
38
History of Avermectin and Ivermectin, with Notes on the History of Other Macrocyclic Lactone Antiparasitic Agents
Current Pharmaceutical Biotechnology
2012
179
39
Mucopolysaccharidosis Type IVA (Morquio A Disease): Clinical Review and Current Treatment: A Special Review
Current Pharmaceutical Biotechnology
2011
178
40
Art and Artefacts of Fluorescence Correlation Spectroscopy
Current Pharmaceutical Biotechnology
2004
177
41
Biopharmaceutical Powders Particle Formation and Formulation Considerations
Current Pharmaceutical Biotechnology
2000
176
42
From Production of Peptides in Milligram Amounts for Research to Multi-Tons Quantities for Drugs of the Future
Current Pharmaceutical Biotechnology
2004
174
43
Spirulina in Health Care Management
Current Pharmaceutical Biotechnology
2008
174
44
DNAzymes: From Creation In Vitro to Application In Vivo
Current Pharmaceutical Biotechnology
2004
171
45
Polyphenols: Well Beyond The Antioxidant Capacity: Gallic Acid and Related Compounds as Neuroprotective Agents: You are What You Eat!
Current Pharmaceutical Biotechnology
2014
171
46
Monitoring Cell Therapy Using Iron Oxide MR Contrast Agents
Current Pharmaceutical Biotechnology
2004
169
47
Phage Therapy for Plant Disease Control
Current Pharmaceutical Biotechnology
2010
168
48
Crocetin: an Agent Derived from Saffron for Prevention and Therapy for Cancer
Current Pharmaceutical Biotechnology
2012
168
49
Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer
Current Pharmaceutical Biotechnology
2012
167
50
Pharmacological Inhibitors of Fatty Acid Synthase (FASN)-Catalyzed Endogenous Fatty Acid Biogenesis: A New Family of Anti-Cancer Agents?
Current Pharmaceutical Biotechnology
2006
163
site/software ©
exaly
; All materials licenced under
CC by-SA
.